A Prospective, Randomized, Multicenter Study Evaluating the Safety and Efficacy of Two Dosing Regimens of Daclizumab Compared to No Antibody Induction in Simultaneous Kidney–Pancreas Transplantation: Results at 3 Years-Reference-Cited by-同舟云学术

A Prospective, Randomized, Multicenter Study Evaluating the Safety and Efficacy of Two Dosing Regimens of Daclizumab Compared to No Antibody Induction in Simultaneous Kidney–Pancreas Transplantation: Results at 3 Years

Published:2005-10 Issue:8 Volume:37 Page:3531-3534
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Stratta R.J.,Alloway R.R.,Lo A.,Hodge E.E.

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference10 articles.

1. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation;Vincenti;N Engl J Med,1998

2. Reduction of acute renal allograft rejection by daclizumab;Nashan;Transplantation,1999

3. Daclizumab prevents acute rejection and improves patient survival post-transplantation;Ekberg;Transpl Int,2000

4. Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation;Vincenti;Am J Transplant,2003

5. Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation;Ahsan;Am J Transplant,2002

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Primary Simultaneous Pancreas-kidney Transplants by Induction Agent in the United States;Transplantation Direct;2022-11-17

2. A Network Meta-Analysis of Induction Immunosuppression for Simultaneous Pancreas-Kidney Transplant From Randomized Clinical Trials;Experimental and Clinical Transplantation;2021-05

3. Working towards an ERAS Protocol for Pancreatic Transplantation: A Narrative Review;Journal of Clinical Medicine;2021-04-01

4. Induction and Immunosuppressive Management of Pancreas Transplant Recipients;Current Pharmaceutical Design;2020-08-31

5. Immunosuppression for pancreas allo-transplantation;Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas;2020